Lonza expands Swiss drug product site, adds 50 jobs
Lonza will feed demand for its drug quality testing and formulation capabilities through an expansion at its Drug Product Services site in Basel, Switzerland.
Archives for August 24, 2017
Samsung Bioepis ups EU presence with Humira biosimilar approval
Imraldi becomes the second version of AbbVie’s best-selling biologic Humira (adalimumab) to be approved and the fourth biosimilar success for Samsung Bioepis in Europe.
CEO predicts fungal-based protein expression will be a 'CHO Stopper'
CHO platforms unsustainable for biopharma's future, says Dyadic
Industry is feeling the low yield and high cost limitations of the CHO cell line and must look to alternatives to make next-generation biological products, says fungal-based protein expression firm Dyadic International.